# Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)

Study · id `cardio:ct-nct04491136` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04491136](<https://clinicaltrials.gov/study/NCT04491136>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04491136

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 201 participants.

## Technical summary

Registry record NCT04491136. Allocation not applicable; no masking; primary purpose treatment. Start 2020-11-11 (actual); primary completion 2023-06-08 (actual). Results posted on 2024-10-17.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 201 participants (enrolled count; ClinicalTrials.gov record NCT04491136, source copy `cardio:ctgov-nct04491136-2025-05-16`, retrieved 2026-10-26)
- Started: 2020-11-11 (actual) (ClinicalTrials.gov record NCT04491136, source copy `cardio:ctgov-nct04491136-2025-05-16`, retrieved 2026-10-26)
- Primary completion: 2023-06-08 (actual) (ClinicalTrials.gov record NCT04491136, source copy `cardio:ctgov-nct04491136-2025-05-16`, retrieved 2026-10-26)
- Completion: 2023-06-08 (actual) (ClinicalTrials.gov record NCT04491136, source copy `cardio:ctgov-nct04491136-2025-05-16`, retrieved 2026-10-26)
- Results first posted: 2024-10-17 (ClinicalTrials.gov record NCT04491136, source copy `cardio:ctgov-nct04491136-2025-05-16`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04491136, source copy `cardio:ctgov-nct04491136-2025-05-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04491136-2025-05-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
- Acronym: RHYTHM
- Condition: Heart Failure
- Intervention (Drug): ACEI/ARB
- Intervention (Drug): ARNI
- Lead sponsor: Novartis Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Novartis (`cardio:novartis`)

## Provenance

Content hash: ecb8c95fcbc6aa15ccd5b3fafe906e80a41122cc50f569c0c16e3118e804c43d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
